LEADER 03040nam 22005534a 450 001 996205519303316 005 20230617005450.0 010 $a1-280-74796-X 010 $a9786610747962 010 $a0-470-98482-1 010 $a0-470-99481-9 010 $a1-4051-7259-2 035 $a(CKB)1000000000341960 035 $a(EBL)284149 035 $a(OCoLC)437176066 035 $a(SSID)ssj0000179615 035 $a(PQKBManifestationID)11165517 035 $a(PQKBTitleCode)TC0000179615 035 $a(PQKBWorkID)10137869 035 $a(PQKB)11133455 035 $a(MiAaPQ)EBC284149 035 $a(EXLCZ)991000000000341960 100 $a20041207d2005 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aInnovative management of atrial fibrillation$b[electronic resource] /$fedited by David Schwartzman and Marco A. Zenati 210 $aMalden, Mass. $cBlackwell Futura$d2005 215 $a1 online resource (210 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-2209-9 320 $aIncludes bibliographical references and index. 327 $aInnovative Management of Atrial Fibrillation; Contents; List of Contributors; Preface; Part I On the Atrial Substrate; 1 Electrophysiological Basis of Atrial Fibrillation; 2 Neurological Basis of Atrial Fibrillation; 3 Mechanical Basis of Atrial Fibrillation; 4 Molecular Basis of Atrial Fibrillation; 5 Atrial Plasticity; Part II Developing Strategies for AF Management; 6 Atrioventricular Node Ablation; 7 Percutaneous Atrial Catheter Ablation; 8 Implantable Device Therapy; 9 Surgical Ablation Therapy I: Maze Procedure; 10 Surgical Ablation Therapy II: Endocardium-Based Catheter Ablation 327 $a11 Surgical Ablation Therapy III: Epicardium-Based Catheter Ablation12 Modification of the Left Atrial Appendage; Part III Potential Areas of Opportunity for AF Management; 13 Transpericardial Therapy; 14 Gene Therapy; 15 Tissue Engineering; Index 330 $aAtrial fibrillation is underdiagnosed and preventative strategies are underutilized. The disease is estimated to rise to an epidemic level, increasing by over 50% by the end of the decade, occurring commonly in the setting of otherwise "healthy" aging. Innovative Management of Atrial Fibrillation provides a forum for a full discussion on this topical matter. Distinguished experts from both electrophysiology and cardiac surgery place their work in the context of future development, examining the short-comings of current pharmacological treatments. This results in a uni 606 $aAtrial fibrillation$xTreatment 615 0$aAtrial fibrillation$xTreatment. 676 $a616.128 701 $aSchwartzman$b David$f1959-$0969037 701 $aZenati$b Marco$0969038 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996205519303316 996 $aInnovative management of atrial fibrillation$92201518 997 $aUNISA